1. Home
  2. KRNY vs MRVI Comparison

KRNY vs MRVI Comparison

Compare KRNY & MRVI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Kearny Financial Corp

KRNY

Kearny Financial Corp

HOLD

Current Price

$7.98

Market Cap

504.9M

Sector

Finance

ML Signal

HOLD

Logo Maravai LifeSciences Holdings Inc.

MRVI

Maravai LifeSciences Holdings Inc.

HOLD

Current Price

$3.28

Market Cap

472.8M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
KRNY
MRVI
Founded
1884
2014
Country
United States
United States
Employees
N/A
N/A
Industry
Savings Institutions
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
504.9M
472.8M
IPO Year
2014
2020

Fundamental Metrics

Financial Performance
Metric
KRNY
MRVI
Price
$7.98
$3.28
Analyst Decision
Buy
Buy
Analyst Count
2
4
Target Price
$8.00
$4.13
AVG Volume (30 Days)
286.4K
1.9M
Earning Date
04-23-2026
05-11-2026
Dividend Yield
5.47%
N/A
EPS Growth
130.22
14.29
EPS
0.30
N/A
Revenue
$2,580,000.00
$185,743,000.00
Revenue This Year
$3.89
$12.44
Revenue Next Year
$17.52
$7.90
P/E Ratio
$26.80
N/A
Revenue Growth
36.00
N/A
52 Week Low
$5.76
$1.67
52 Week High
$8.50
$4.11

Technical Indicators

Market Signals
Indicator
KRNY
MRVI
Relative Strength Index (RSI) 61.88 57.59
Support Level $7.77 $3.25
Resistance Level $8.42 $3.93
Average True Range (ATR) 0.16 0.16
MACD 0.08 0.04
Stochastic Oscillator 76.47 86.11

Price Performance

Historical Comparison
KRNY
MRVI

About KRNY Kearny Financial Corp

Kearny Financial Corp is a federally-chartered stock savings bank. The bank is engaged in the business of attracting deposits from the general public in New Jersey and New York, and using these deposits, together with other funds, to originate or purchase loans for its portfolios and invest in securities. The bank's loan portfolio is chiefly comprised of loans collateralized by commercial and residential real estate. The bank's primary source of income is net interest income.

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

Share on Social Networks: